Patient Provider Communication and Interaction in a Virtual Clinical Setting
NCT ID: NCT00669188
Last Updated: 2024-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
326 participants
INTERVENTIONAL
2008-04-24
2020-07-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A few studies have explored factors which influence patient-provider communication in a controlled setting. However, more information is needed about how different factors affect communication so that it can be improved.
Third- and fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.
At the research center, participants will use a virtual reality headset to view a virtual clinic environment and interact with a virtual patient.
After interacting with the virtual patient, participants will complete a questionnaire about their experience within the virtual clinic and other research-related information.
The total time for the study visit is 60 minutes.
Eligibility:
Third- and fourth-year medical students at least 18 years of age. You may not take part in the study if you have a history of seizures and/or are pregnant.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Remote Treatment on Medical Provider Creative Thinking and Patient Disclosure
NCT06784635
Controlling Hypertension Outcomes by Improved Communication & Engagement
NCT01134887
A Pilot Study to Improve Patient-Doctor Communication
NCT01606930
Assessment of Comskil Training Through Videorecording and Patient Surveys
NCT00943813
Pilot Study to Improve Care Coordination
NCT02386189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Third- or fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.
Study participants will perform one task and complete one set of questions at the study appointment. The task involves viewing a virtual patient s health information and interacting with the virtual patient in a virtual environment clinical scenario. While in the virtual environment, the subject wears a head-mounted video unit that allows him or her to see elements of the environment. The activities in the virtual environment take about 15 minutes. The total time for the study is about 60 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Information Type 1
genetic risk information
Information
Information
Information Type 2
information absent
Information absent
Information
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Information absent
Information
Information
Information
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Human Genome Research Institute (NHGRI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Persky, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Human Genome Research Institute (NHGRI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-HG-0122
Identifier Type: -
Identifier Source: secondary_id
080122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.